Clofazimine

In the US, Clofazimine (clofazimine systemic) is a member of the drug class leprostatics and is used to treat Leprosy, Leprosy - Dapsone-Resistant, Leprosy - Dapsone-Sensitive and Leprosy - Erythema Nodosum Leprosum.

US matches:

• Clofazimine

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J04BA01

CAS registry number (Chemical Abstracts Service)

0002030-63-9

Chemical Formula

C27-H22-Cl2-N4

Molecular Weight

473

Therapeutic Category

Antileprotic agent

Chemical Name

2-Phenazinamine, N,5-bis(4-chlorophenyl)-3,5-dihydro-3-[(1-methylethyl)imino]-

Foreign Names

• Clofaziminum (Latin)
• Clofazimin (German)
• Clofazimine (French)
• Clofazimina (Spanish)

Generic Names

• Clofazimine (OS: USAN, BANM)
• B 663 (IS)
• G 30320 (IS)
• NSC 141046 (IS)
• Riminophenazine (IS)
• Clofazimine (PH: Ph. Eur. 6, Ph. Franç. Xe édit, Ph. Int. 4, USP 32, BP 2010)
• Clofaziminum (PH: Ph. Int. 4, Ph. Eur. 6)

Brand Names

• Clofozine
  AstraZeneca, India



• Hansepran
  Sarabhai, India



• Lamcoin
  Pond's, Thailand



• Lampren
  Novartis, Netherlands; Padro, Spain; Sandoz, Japan



• Lamprene
  Novartis, Australia; Novartis, Ethiopia; Novartis, Ghana; Novartis, Guyana; Novartis, Kenya; Novartis, Libya; Novartis, Nigeria; Novartis, New Zealand; Novartis, Sudan; Novartis, Tanzania; Novartis, United States; Novartis, Zimbabwe



• Lamprène
  Novartis, France

International Drug Name Search

Glossary

BANM	British Approved Name (Modified)
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.